Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Autophagy and mesenchymal cell fibrogenesis.

Biochimica et biophysica acta

Hilscher M, Hernandez-Gea V, Friedman SL.
PMID: 23142802
Biochim Biophys Acta. 2012 Jul;1831(7):972-8. doi: 10.1016/j.bbadis.2012.11.001. Epub 2012 Nov 09.

Autophagy is a catabolic pathway essential for cellular energy homeostasis that involves the self-degradation of intracellular components in lysosomes. This process has been implicated in the pathophysiology of many human disorders, including infection, cancer, and fibrosis. Autophagy is also...

Cite
Hilscher M, Hernandez-Gea V, Friedman SL. Autophagy and mesenchymal cell fibrogenesis. Biochim Biophys Acta. 2012;1831(7):972-8doi: 10.1016/j.bbadis.2012.11.001.
Hilscher, M., Hernandez-Gea, V., & Friedman, S. L. (2012). Autophagy and mesenchymal cell fibrogenesis. Biochimica et biophysica acta, 1831(7), 972-8. https://doi.org/10.1016/j.bbadis.2012.11.001
Hilscher, Moira, et al. "Autophagy and mesenchymal cell fibrogenesis." Biochimica et biophysica acta vol. 1831,7 (2012): 972-8. doi: https://doi.org/10.1016/j.bbadis.2012.11.001
Hilscher M, Hernandez-Gea V, Friedman SL. Autophagy and mesenchymal cell fibrogenesis. Biochim Biophys Acta. 2012 Jul;1831(7):972-8. doi: 10.1016/j.bbadis.2012.11.001. Epub 2012 Nov 09. PMID: 23142802; PMCID: PMC3608743.
Copy Download .nbib Format: NLM
The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD.

NeuroImage. Clinical

Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM.
PMID: 34952353
Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20.

BACKGROUND: Posttraumatic Stress Disorder (PTSD) is commonly treated with exposure-based cognitive therapies that are based on the principles of fear acquisition and extinction learning. Elevations in one of the major endocannabinoids (anandamide) either via inhibition of the primary degrading...

Cite
Crombie KM, Privratsky AA, Schomaker CM, et al. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021;33:102922doi: 10.1016/j.nicl.2021.102922.
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M., Ross, M. C., Sartin-Tarm, A., Sellnow, K., Binder, E. B., Andrew James, G., & Cisler, J. M. (2021). The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. NeuroImage. Clinical, 33102922. https://doi.org/10.1016/j.nicl.2021.102922
Crombie, Kevin M, et al. "The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD." NeuroImage. Clinical vol. 33 (2021): 102922. doi: https://doi.org/10.1016/j.nicl.2021.102922
Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20. PMID: 34952353; PMCID: PMC8715233.
Copy Download .nbib Format: NLM
The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD.

NeuroImage. Clinical

Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM.
PMID: 34952353
Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20.

BACKGROUND: Posttraumatic Stress Disorder (PTSD) is commonly treated with exposure-based cognitive therapies that are based on the principles of fear acquisition and extinction learning. Elevations in one of the major endocannabinoids (anandamide) either via inhibition of the primary degrading...

Cite
Crombie KM, Privratsky AA, Schomaker CM, et al. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021;33:102922doi: 10.1016/j.nicl.2021.102922.
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M., Ross, M. C., Sartin-Tarm, A., Sellnow, K., Binder, E. B., Andrew James, G., & Cisler, J. M. (2021). The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. NeuroImage. Clinical, 33102922. https://doi.org/10.1016/j.nicl.2021.102922
Crombie, Kevin M, et al. "The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD." NeuroImage. Clinical vol. 33 (2021): 102922. doi: https://doi.org/10.1016/j.nicl.2021.102922
Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20. PMID: 34952353.
Copy Download .nbib Format: NLM
The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD.

NeuroImage. Clinical

Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM.
PMID: 34952353
Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20.

BACKGROUND: Posttraumatic Stress Disorder (PTSD) is commonly treated with exposure-based cognitive therapies that are based on the principles of fear acquisition and extinction learning. Elevations in one of the major endocannabinoids (anandamide) either via inhibition of the primary degrading...

Cite
Crombie KM, Privratsky AA, Schomaker CM, et al. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021;33:102922doi: 10.1016/j.nicl.2021.102922.
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M., Ross, M. C., Sartin-Tarm, A., Sellnow, K., Binder, E. B., Andrew James, G., & Cisler, J. M. (2021). The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. NeuroImage. Clinical, 33102922. https://doi.org/10.1016/j.nicl.2021.102922
Crombie, Kevin M, et al. "The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD." NeuroImage. Clinical vol. 33 (2021): 102922. doi: https://doi.org/10.1016/j.nicl.2021.102922
Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20. PMID: 34952353.
Copy Download .nbib Format: NLM
Congestive hepatopathy.

Clinical liver disease

Hilscher M, Sanchez W.
PMID: 31041066
Clin Liver Dis (Hoboken). 2016 Oct 02;8(3):68-71. doi: 10.1002/cld.573. eCollection 2016 Sep.

No abstract available.

Cite
Hilscher M, Sanchez W. Congestive hepatopathy. Clin Liver Dis (Hoboken). 2016;8(3):68-71doi: 10.1002/cld.573.
Hilscher, M., & Sanchez, W. (2016). Congestive hepatopathy. Clinical liver disease, 8(3), 68-71. https://doi.org/10.1002/cld.573
Hilscher, Moira, and Sanchez, William. "Congestive hepatopathy." Clinical liver disease vol. 8,3 (2016): 68-71. doi: https://doi.org/10.1002/cld.573
Hilscher M, Sanchez W. Congestive hepatopathy. Clin Liver Dis (Hoboken). 2016 Oct 02;8(3):68-71. doi: 10.1002/cld.573. eCollection 2016 Sep. PMID: 31041066; PMCID: PMC6490201.
Copy Download .nbib Format: NLM
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis.

Scientific reports

Michel M, Hess C, Kaps L, Kremer WM, Hilscher M, Galle PR, Moehler M, Schattenberg JM, Wörns MA, Labenz C, Nagel M.
PMID: 34654829
Sci Rep. 2021 Oct 15;11(1):20506. doi: 10.1038/s41598-021-00119-7.

Methylglyoxal (MGO) is a highly reactive dicarbonyl species that forms advanced glycation end products (AGEs). The binding of these AGEs to their receptor (RAGE) causes and sustains severe inflammation. Systemic inflammation is postulated to be a major driver in...

Cite
Michel M, Hess C, Kaps L, et al. Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis. Sci Rep. 2021;11(1):20506doi: 10.1038/s41598-021-00119-7.
Michel, M., Hess, C., Kaps, L., Kremer, W. M., Hilscher, M., Galle, P. R., Moehler, M., Schattenberg, J. M., Wörns, M. A., Labenz, C., & Nagel, M. (2021). Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis. Scientific reports, 11(1), 20506. https://doi.org/10.1038/s41598-021-00119-7
Michel, Maurice, et al. "Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis." Scientific reports vol. 11,1 (2021): 20506. doi: https://doi.org/10.1038/s41598-021-00119-7
Michel M, Hess C, Kaps L, Kremer WM, Hilscher M, Galle PR, Moehler M, Schattenberg JM, Wörns MA, Labenz C, Nagel M. Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis. Sci Rep. 2021 Oct 15;11(1):20506. doi: 10.1038/s41598-021-00119-7. PMID: 34654829; PMCID: PMC8519993.
Copy Download .nbib Format: NLM
The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD.

NeuroImage. Clinical

Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM.
PMID: 34952353
Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20.

BACKGROUND: Posttraumatic Stress Disorder (PTSD) is commonly treated with exposure-based cognitive therapies that are based on the principles of fear acquisition and extinction learning. Elevations in one of the major endocannabinoids (anandamide) either via inhibition of the primary degrading...

Cite
Crombie KM, Privratsky AA, Schomaker CM, et al. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021;33:102922doi: 10.1016/j.nicl.2021.102922.
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M., Ross, M. C., Sartin-Tarm, A., Sellnow, K., Binder, E. B., Andrew James, G., & Cisler, J. M. (2021). The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. NeuroImage. Clinical, 33102922. https://doi.org/10.1016/j.nicl.2021.102922
Crombie, Kevin M, et al. "The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD." NeuroImage. Clinical vol. 33 (2021): 102922. doi: https://doi.org/10.1016/j.nicl.2021.102922
Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20. PMID: 34952353.
Copy Download .nbib Format: NLM
The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD.

NeuroImage. Clinical

Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM.
PMID: 34952353
Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20.

BACKGROUND: Posttraumatic Stress Disorder (PTSD) is commonly treated with exposure-based cognitive therapies that are based on the principles of fear acquisition and extinction learning. Elevations in one of the major endocannabinoids (anandamide) either via inhibition of the primary degrading...

Cite
Crombie KM, Privratsky AA, Schomaker CM, et al. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021;33:102922doi: 10.1016/j.nicl.2021.102922.
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M., Ross, M. C., Sartin-Tarm, A., Sellnow, K., Binder, E. B., Andrew James, G., & Cisler, J. M. (2021). The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. NeuroImage. Clinical, 33102922. https://doi.org/10.1016/j.nicl.2021.102922
Crombie, Kevin M, et al. "The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD." NeuroImage. Clinical vol. 33 (2021): 102922. doi: https://doi.org/10.1016/j.nicl.2021.102922
Crombie KM, Privratsky AA, Schomaker CM, Heilicher M, Ross MC, Sartin-Tarm A, Sellnow K, Binder EB, Andrew James G, Cisler JM. The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. Neuroimage Clin. 2021 Dec 20;33:102922. doi: 10.1016/j.nicl.2021.102922. Epub 2021 Dec 20. PMID: 34952353; PMCID: PMC8715233.
Copy Download .nbib Format: NLM
More on DNR: Agonizing decisions, haunting questions.

Journal of emergency nursing

Heilicser B.
PMID: 9925670
J Emerg Nurs. 1999 Feb;25(1):5. doi: 10.1016/s0099-1767(99)70140-6.

No abstract available.

Cite
Heilicser B. More on DNR: Agonizing decisions, haunting questions. J Emerg Nurs. 1999;25(1):5doi: 10.1016/s0099-1767(99)70140-6.
Heilicser, B. (1999). More on DNR: Agonizing decisions, haunting questions. Journal of emergency nursing, 25(1), 5. https://doi.org/10.1016/s0099-1767(99)70140-6
Heilicser. "More on DNR: Agonizing decisions, haunting questions." Journal of emergency nursing vol. 25,1 (1999): 5. doi: https://doi.org/10.1016/s0099-1767(99)70140-6
Heilicser B. More on DNR: Agonizing decisions, haunting questions. J Emerg Nurs. 1999 Feb;25(1):5. doi: 10.1016/s0099-1767(99)70140-6. PMID: 9925670.
Copy Download .nbib Format: NLM
Hepatology Highlights.

Hepatology (Baltimore, Md.)

Amir M, Vora RS, Tafesh ZH, Jesudian A, Gupta V, Schwartz RE, Russo N, Danford CJ, Lau DTY, Brown RS, Jalan-Sakrikar N, Maiers JL, Sharma R, Fortune BE, Hilscher M, Aseem SO.
PMID: 31661168
Hepatology. 2019 Nov;70(5):1497-1499. doi: 10.1002/hep.30995.

No abstract available.

Cite
Amir M, Vora RS, Tafesh ZH, et al. Hepatology Highlights. Hepatology. 2019;70(5):1497-1499doi: 10.1002/hep.30995.
Amir, M., Vora, R. S., Tafesh, Z. H., Jesudian, A., Gupta, V., Schwartz, R. E., Russo, N., Danford, C. J., Lau, D. T. Y., Brown, R. S., Jalan-Sakrikar, N., Maiers, J. L., Sharma, R., Fortune, B. E., Hilscher, M., & Aseem, S. O. (2019). Hepatology Highlights. Hepatology (Baltimore, Md.), 70(5), 1497-1499. https://doi.org/10.1002/hep.30995
Amir, Muhammad, et al. "Hepatology Highlights." Hepatology (Baltimore, Md.) vol. 70,5 (2019): 1497-1499. doi: https://doi.org/10.1002/hep.30995
Amir M, Vora RS, Tafesh ZH, Jesudian A, Gupta V, Schwartz RE, Russo N, Danford CJ, Lau DTY, Brown RS, Jalan-Sakrikar N, Maiers JL, Sharma R, Fortune BE, Hilscher M, Aseem SO. Hepatology Highlights. Hepatology. 2019 Nov;70(5):1497-1499. doi: 10.1002/hep.30995. PMID: 31661168.
Copy Download .nbib Format: NLM
Functional imaging correlates of childhood trauma: A qualitative review of past research and emerging trends.

Pharmacology, biochemistry, and behavior

Ross MC, Heilicher M, Cisler JM.
PMID: 34780877
Pharmacol Biochem Behav. 2021 Dec;211:173297. doi: 10.1016/j.pbb.2021.173297. Epub 2021 Nov 12.

Childhood trauma exposure is common and is associated with poor clinical outcomes in adolescence along with mental health and sociodemographic challenges in adulthood. While many strategies exist to investigate the biological imprint of childhood trauma exposure, functional neuroimaging is...

Cite
Ross MC, Heilicher M, Cisler JM. Functional imaging correlates of childhood trauma: A qualitative review of past research and emerging trends. Pharmacol Biochem Behav. 2021;211:173297doi: 10.1016/j.pbb.2021.173297.
Ross, M. C., Heilicher, M., & Cisler, J. M. (2021). Functional imaging correlates of childhood trauma: A qualitative review of past research and emerging trends. Pharmacology, biochemistry, and behavior, 211173297. https://doi.org/10.1016/j.pbb.2021.173297
Ross, Marisa C, et al. "Functional imaging correlates of childhood trauma: A qualitative review of past research and emerging trends." Pharmacology, biochemistry, and behavior vol. 211 (2021): 173297. doi: https://doi.org/10.1016/j.pbb.2021.173297
Ross MC, Heilicher M, Cisler JM. Functional imaging correlates of childhood trauma: A qualitative review of past research and emerging trends. Pharmacol Biochem Behav. 2021 Dec;211:173297. doi: 10.1016/j.pbb.2021.173297. Epub 2021 Nov 12. PMID: 34780877; PMCID: PMC8675038.
Copy Download .nbib Format: NLM
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis.

Hepatology communications

Gairing SJ, Anders J, Kaps L, Nagel M, Michel M, Kremer WM, Hilscher M, Galle PR, Schattenberg JM, Wörns MA, Labenz C.
PMID: 35032100
Hepatol Commun. 2022 Jan 14; doi: 10.1002/hep4.1883. Epub 2022 Jan 14.

Diagnosis of minimal hepatic encephalopathy (MHE) requires psychometric testing, which is time-consuming and often neglected in clinical practice. Elevated Interleukin-6 (IL-6) serum levels have been linked to MHE. The aim of this study was to investigate the usefulness of...

Cite
Gairing SJ, Anders J, Kaps L, et al. Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatol Commun. 2022;doi: 10.1002/hep4.1883.
Gairing, S. J., Anders, J., Kaps, L., Nagel, M., Michel, M., Kremer, W. M., Hilscher, M., Galle, P. R., Schattenberg, J. M., Wörns, M. A., & Labenz, C. (2022). Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology communications, . https://doi.org/10.1002/hep4.1883
Gairing, Simon Johannes, et al. "Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis." Hepatology communications vol. (2022). doi: https://doi.org/10.1002/hep4.1883
Gairing SJ, Anders J, Kaps L, Nagel M, Michel M, Kremer WM, Hilscher M, Galle PR, Schattenberg JM, Wörns MA, Labenz C. Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatol Commun. 2022 Jan 14; doi: 10.1002/hep4.1883. Epub 2022 Jan 14. PMID: 35032100.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries